DGX — —
Loading…
— —
PREV CLOSE — OPEN — DAY RANGE —
Analyzing 0%
MASTER — —
ESEN VERDICT
Analyzing…
Horizon6–12M
Confidence—
Data coverage—

DGX Stock AI Analysis

ESEN AI analysis of DGX stock updated every 12 hours.

ESEN Institutional Analysis

DGX Systematic Research

Quest Diagnostics demonstrates defensive characteristics within the diagnostic services sector, evidenced by a beta of 0.54 that positions the equity as considerably less volatile than broader market indices. Trading at $233.01 with a market capitalization of $25.7 billion, the company sits near the upper end of its 52-week range of $166.75–$240.13, reflecting sustained institutional interest in healthcare infrastructure assets.

Systematic screening highlights several fundamental strengths:

  • Accelerating profitability metrics: The 13.01% year-over-year EPS growth outpaces revenue expansion of 9.87%, indicating operational leverage and margin improvement. Net margin of 9.19% translates to trailing twelve-month earnings per share of $9.44, supporting the current P/E ratio of 24.38.
  • Stable balance sheet structure: The debt-to-equity ratio of 0.82 remains within manageable parameters for capital-intensive laboratory operations, while the current ratio of 1.04 suggests adequate short-term liquidity coverage.
  • Consistent return generation: ROE of 14.49% exceeds the company's cost of equity for most modeling scenarios, with ROA of 6.43% reflecting asset-intensive business model characteristics typical of nationwide diagnostic networks.

The research perspective identifies valuation compression risk, as the P/B ratio of 2.69 represents premium pricing relative to book value of $65.18 per share. Regulatory reimbursement pressures present ongoing margin headwinds within clinical laboratory services. Against peers including Laboratory Corporation (LH), Cigna (CI), and CVS Health (CVS), DGX maintains differentiated exposure as a pure-play diagnostics provider with higher operating margins of 14.1%, offering portfolio diversification within healthcare services allocations.

Analysis updated monthly based on systematic screening of fundamentals, profitability, growth, and peer positioning.

Related Stocks
AAPL NVDA MSFT AMZN GOOGL META TSLA AVGO JPM V MA LLY UNH XOM JNJ WMT PG HD MRK COST BAC ABBV CRM CVX ORCL KO PEP AMD NFLX ADBE

Explore AI analysis for top stocks — Full Rankings · AI Screener · Earnings Calendar